Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2018 - Product Image

Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516392
  • Report
  • Region: Global
  • Fore Pharma
1 of 3
The researcher announced the results of its Chronic Obstructive Pulmonary Disease patients study in a new research ‘Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease diagnosed patients, and Chronic Obstructive Pulmonary Disease treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Chronic Obstructive Pulmonary Disease derived from epidemiological analysis, patients diagnosed with Chronic Obstructive Pulmonary Disease, and patients treated with a drug therapy.

The research study helps executives estimate Chronic Obstructive Pulmonary Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Chronic Obstructive Pulmonary Disease prevalence, Chronic Obstructive Pulmonary Disease diagnosis rate, and Chronic Obstructive Pulmonary Disease treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:
  • Chronic Obstructive Pulmonary Disease Patient Flow
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Chronic Obstructive Pulmonary Disease Diagnosed Patients
  • Chronic Obstructive Pulmonary Disease Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Chronic Obstructive Pulmonary Disease: Disease Definition
2. Global Chronic Obstructive Pulmonary Disease Patient Flow
2A. Global Chronic Obstructive Pulmonary Disease Prevalence
2B. Global Chronic Obstructive Pulmonary Disease Diagnosed Patients
2C. Global Chronic Obstructive Pulmonary Disease Treated Patients
3. Chronic Obstructive Pulmonary Disease Patient Flow in the US
3A. Chronic Obstructive Pulmonary Disease Prevalence in the US
3B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in the US
3C. Chronic Obstructive Pulmonary Disease Treated Patients in the US
4. Chronic Obstructive Pulmonary Disease Patient Flow in Europe
4A. Chronic Obstructive Pulmonary Disease Prevalence in Europe
4B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Europe
4C. Chronic Obstructive Pulmonary Disease Treated Patients in Europe
5. Chronic Obstructive Pulmonary Disease Patient Flow in Germany
5A. Chronic Obstructive Pulmonary Disease Prevalence in Germany
5B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Germany
5C. Chronic Obstructive Pulmonary Disease Treated Patients in Germany
6. Chronic Obstructive Pulmonary Disease Patient Flow in France
6A. Chronic Obstructive Pulmonary Disease Prevalence in France
6B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in France
6C. Chronic Obstructive Pulmonary Disease Treated Patients in France
7. Chronic Obstructive Pulmonary Disease Patient Flow in Spain
7A. Chronic Obstructive Pulmonary Disease Prevalence in Spain
7B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Spain
7C. Chronic Obstructive Pulmonary Disease Treated Patients in Spain
8. Chronic Obstructive Pulmonary Disease Patient Flow in Italy
8A. Chronic Obstructive Pulmonary Disease Prevalence in Italy
8B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Italy
8C. Chronic Obstructive Pulmonary Disease Treated Patients in Italy
9. Chronic Obstructive Pulmonary Disease Patient Flow in UK
9A. Chronic Obstructive Pulmonary Disease Prevalence in UK
9B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in UK
9C. Chronic Obstructive Pulmonary Disease Treated Patients in UK
10. Chronic Obstructive Pulmonary Disease Patient Flow in Japan
10A. Chronic Obstructive Pulmonary Disease Prevalence in Japan
10B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Japan
10C. Chronic Obstructive Pulmonary Disease Treated Patients in Japan
11. Research Methodology

List of Tables
Table 1: Global Chronic Obstructive Pulmonary Disease Patient Flow, 2017
Table 2: Global Chronic Obstructive Pulmonary Disease Patient Flow Forecast, 2017 - 2026
Table 3: Chronic Obstructive Pulmonary Disease Patient Flow in the US, 2017
Table 4: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in the US, 2017 - 2026
Table 5: Chronic Obstructive Pulmonary Disease Patient Flow in Europe, 2017
Table 6: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Europe, 2017 - 2026
Table 7: Chronic Obstructive Pulmonary Disease Patient Flow in Germany, 2017
Table 8: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Germany, 2017 - 2026
Table 9: Chronic Obstructive Pulmonary Disease Patient Flow in France, 2017
Table 10: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in France, 2017 - 2026
Table 11: Chronic Obstructive Pulmonary Disease Patient Flow in Spain, 2017
Table 12: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Spain, 2017 - 2026
Table 13: Chronic Obstructive Pulmonary Disease Patient Flow in Italy, 2017
Table 14: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Italy, 2017 - 2026
Table 15: Chronic Obstructive Pulmonary Disease Patient Flow in UK, 2017
Table 16: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in UK, 2017 - 2026
Table 17: Chronic Obstructive Pulmonary Disease Patient Flow in Japan, 2017
Table 18: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Japan, 2017 - 2026

List of Figures
Figures 1: Global Chronic Obstructive Pulmonary Disease Patient Flow, 2017
Figure 2: Global Chronic Obstructive Pulmonary Disease Patient Flow Forecast, 2017 - 2026
Figure 3: Chronic Obstructive Pulmonary Disease Patient Flow in the US, 2017
Figure 4: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in the US, 2017 - 2026
Figure 5: Chronic Obstructive Pulmonary Disease Patient Flow in Europe, 2017
Figure 6: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Europe, 2017 - 2026
Figure 7: Chronic Obstructive Pulmonary Disease Patient Flow in Germany, 2017
Figure 8: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Germany, 2017 - 2026
Figure 9: Chronic Obstructive Pulmonary Disease Patient Flow in France, 2017
Figure 10: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in France, 2017 - 2026
Figure 11: Chronic Obstructive Pulmonary Disease Patient Flow in Spain, 2017
Figure 12: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Spain, 2017 - 2026
Figure 13: Chronic Obstructive Pulmonary Disease Patient Flow in Italy, 2017
Figure 14: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Italy, 2017 - 2026
Figure 15: Chronic Obstructive Pulmonary Disease Patient Flow in UK, 2017
Figure 16: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in UK, 2017 - 2026
Figure 17: Chronic Obstructive Pulmonary Disease Patient Flow in Japan, 2017
Figure 18: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Japan, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll